報價延遲最少15分鐘:2025/06/05 04:06 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
5.14 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-18.66/-1.31
|
|
企業價值
38.12M
|
| 資產負債 |
|
每股賬面淨值
4.40
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
299.23K
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/05 04:06 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies. |